pf-07104091
pfizer
['breast', 'pf-07104091', 'pfizer']
 presented data at the and revealed that pf-07104091 monotherapy demonstrated a remarkable tolerability and promising antitumor effects in heavily pretreated patients with hr+/her2- metastatic breast cancer. get more insight at: 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry